The University of Chicago Header Logo

Connection

Anita Chong to Graft Rejection

This is a "connection" page, showing publications Anita Chong has written about Graft Rejection.
Connection Strength

14.044
  1. Cutting to the chase: Pruning alloreactive T cells. Immunity. 2025 02 11; 58(2):270-272.
    View in: PubMed
    Score: 0.559
  2. Beyond Adaptive Alloreactivity: Contribution of Innate B Cells to Allograft Inflammation and Rejection. Transplantation. 2023 01 01; 107(1):98-104.
    View in: PubMed
    Score: 0.479
  3. The First ITS Meeting. Transplantation. 2020 06; 104(6):1114-1116.
    View in: PubMed
    Score: 0.404
  4. B cells as antigen-presenting cells in transplantation rejection and tolerance. Cell Immunol. 2020 03; 349:104061.
    View in: PubMed
    Score: 0.395
  5. Desensitization in the Era of Precision Medicine: Moving From the Bench to Bedside. Transplantation. 2019 08; 103(8):1574-1581.
    View in: PubMed
    Score: 0.381
  6. Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejection. Am J Transplant. 2019 08; 19(8):2155-2163.
    View in: PubMed
    Score: 0.373
  7. Urinary nanosensors of early transplant rejection. Nat Biomed Eng. 2019 04; 3(4):251-252.
    View in: PubMed
    Score: 0.372
  8. New insights into the development of B cell responses: Implications for solid organ transplantation. Hum Immunol. 2019 Jun; 80(6):378-384.
    View in: PubMed
    Score: 0.359
  9. Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans. Transplantation. 2017 11; 101(11):2671-2681.
    View in: PubMed
    Score: 0.338
  10. Transplantation tolerance: don't forget about the B cells. Clin Exp Immunol. 2017 08; 189(2):171-180.
    View in: PubMed
    Score: 0.322
  11. Transplantation tolerance after allograft rejection. Curr Opin Organ Transplant. 2017 Feb; 22(1):64-70.
    View in: PubMed
    Score: 0.320
  12. Tracing Donor-MHC Class II Reactive B cells in Mouse Cardiac Transplantation: Delayed CTLA4-Ig Treatment Prevents Memory Alloreactive B-Cell Generation. Transplantation. 2016 08; 100(8):1683-91.
    View in: PubMed
    Score: 0.309
  13. Erosion of Transplantation Tolerance After Infection. Am J Transplant. 2017 01; 17(1):81-90.
    View in: PubMed
    Score: 0.308
  14. Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection. Am J Transplant. 2016 08; 16(8):2312-23.
    View in: PubMed
    Score: 0.303
  15. Spontaneous restoration of transplantation tolerance after acute rejection. Nat Commun. 2015 Jul 07; 6:7566.
    View in: PubMed
    Score: 0.287
  16. Transplantation: molecular phenotyping of T-cell-mediated rejection. Nat Rev Nephrol. 2014 12; 10(12):678-80.
    View in: PubMed
    Score: 0.274
  17. New kid on the pretransplant block: IgG recognizing apoptotic cells. Am J Transplant. 2014 Jul; 14(7):1477-8.
    View in: PubMed
    Score: 0.267
  18. Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients. Transplantation. 2014 Apr 27; 97(8):846-53.
    View in: PubMed
    Score: 0.265
  19. Transplantation tolerance and its outcome during infections and inflammation. Immunol Rev. 2014 Mar; 258(1):80-101.
    View in: PubMed
    Score: 0.262
  20. Lessons and limits of mouse models. Cold Spring Harb Perspect Med. 2013 Dec 01; 3(12):a015495.
    View in: PubMed
    Score: 0.257
  21. The impact of infection and tissue damage in solid-organ transplantation. Nat Rev Immunol. 2012 May 25; 12(6):459-71.
    View in: PubMed
    Score: 0.232
  22. "Tip-toeing" to an assay for transplantation tolerance? Am J Transplant. 2012 Mar; 12(3):519-20.
    View in: PubMed
    Score: 0.224
  23. Bacterial infections, alloimmunity, and transplantation tolerance. Transplant Rev (Orlando). 2011 Jan; 25(1):27-35.
    View in: PubMed
    Score: 0.210
  24. Toll-like receptors (TLRs) in transplantation. Front Biosci (Elite Ed). 2009 06 01; 1(1):36-43.
    View in: PubMed
    Score: 0.188
  25. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance. J Immunol. 2009 Feb 01; 182(3):1314-24.
    View in: PubMed
    Score: 0.184
  26. Toll-like receptor signaling in transplantation. Curr Opin Organ Transplant. 2008 Aug; 13(4):358-65.
    View in: PubMed
    Score: 0.178
  27. Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes. J Immunol. 2008 May 01; 180(9):5991-9.
    View in: PubMed
    Score: 0.175
  28. Long-term control of alloreactive B cell responses by the suppression of T cell help. J Immunol. 2008 May 01; 180(9):6077-84.
    View in: PubMed
    Score: 0.175
  29. Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-gamma receptors. J Immunol. 2008 Jan 01; 180(1):261-8.
    View in: PubMed
    Score: 0.171
  30. TLR engagement prevents transplantation tolerance. Am J Transplant. 2006 Oct; 6(10):2282-91.
    View in: PubMed
    Score: 0.157
  31. APOL1 risk alleles modulate T cell receptor signaling to promote allograft rejection. J Clin Invest. 2026 Aug 03; 136(15).
    View in: PubMed
    Score: 0.153
  32. Mechanisms of donor-specific transfusion synergy with anti-CD154 for transplant acceptance. J Immunol. 2026 03 17; 215(3).
    View in: PubMed
    Score: 0.151
  33. Liver ischemia contributes to early islet failure following intraportal transplantation: benefits of liver ischemic-preconditioning. Am J Transplant. 2006 Jan; 6(1):60-8.
    View in: PubMed
    Score: 0.149
  34. Concurrent antiviral and immunosuppressive activities of leflunomide in vivo. Am J Transplant. 2006 Jan; 6(1):69-75.
    View in: PubMed
    Score: 0.149
  35. CAR Treg synergy with anti-CD154 promotes infectious tolerance and dictates allogeneic heart transplant acceptance. JCI Insight. 2025 04 08; 10(7).
    View in: PubMed
    Score: 0.141
  36. Follicular regulatory T cells restrain kidney allograft rejection in mice by suppressing alloreactive B cells. Nat Commun. 2025 Mar 04; 16(1):2151.
    View in: PubMed
    Score: 0.140
  37. Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation. Cochrane Database Syst Rev. 2024 12 19; 12:CD014966.
    View in: PubMed
    Score: 0.138
  38. Update on the immunological mechanisms of primary graft dysfunction and chronic lung allograft dysfunction. Curr Opin Organ Transplant. 2024 Dec 01; 29(6):412-419.
    View in: PubMed
    Score: 0.137
  39. Cutting Edge: NK cells mediate IgG1-dependent hyperacute rejection of xenografts. J Immunol. 2004 Jun 15; 172(12):7235-8.
    View in: PubMed
    Score: 0.134
  40. Pregnancy dedifferentiates memory CD8+ T cells into hypofunctional cells with exhaustion-enriched programs. JCI Insight. 2024 05 21; 9(13).
    View in: PubMed
    Score: 0.133
  41. Low-affinity CD8+ T cells provide interclonal help to high-affinity CD8+ T cells to augment alloimmunity. Am J Transplant. 2024 Jun; 24(6):933-943.
    View in: PubMed
    Score: 0.130
  42. A transitional B-cell cytokine biomarker for risk stratifying renal transplant patients with borderline rejection. Kidney Int. 2023 04; 103(4):658-660.
    View in: PubMed
    Score: 0.123
  43. The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection. J Immunol. 2003 Feb 01; 170(3):1531-9.
    View in: PubMed
    Score: 0.121
  44. Role of CD4+ and CD8+ T cells in the rejection of concordant pancreas xenografts. Transplantation. 2002 Nov 15; 74(9):1236-41.
    View in: PubMed
    Score: 0.120
  45. Host-versus-commensal immune responses participate in the rejection of colonized solid organ transplants. J Clin Invest. 2022 09 01; 132(17).
    View in: PubMed
    Score: 0.118
  46. From bench to bedside: reversing established antibody responses and desensitization. Curr Opin Organ Transplant. 2022 10 01; 27(5):376-384.
    View in: PubMed
    Score: 0.117
  47. Acute xenograft rejection mediated by antibodies produced independently of TH1/TH2 cytokine profiles. Am J Transplant. 2002 Jul; 2(6):526-34.
    View in: PubMed
    Score: 0.117
  48. Linked sensitization by memory CD4+ T cells prevents costimulation blockade-induced transplantation tolerance. JCI Insight. 2022 06 08; 7(11).
    View in: PubMed
    Score: 0.116
  49. Toward an understanding of allogeneic conflict in pregnancy and transplantation. J Exp Med. 2022 05 02; 219(5).
    View in: PubMed
    Score: 0.115
  50. Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection. Nat Commun. 2021 07 16; 12(1):4372.
    View in: PubMed
    Score: 0.109
  51. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection. Transplantation. 2001 May 27; 71(10):1385-9.
    View in: PubMed
    Score: 0.108
  52. Anti-galactose-alpha(1,3)Galactose antibody production in alpha1, 3-galactosyltransferase gene knockout mice after xeno- and allotransplantation. Transplant Proc. 2000 Aug; 32(5):844-5.
    View in: PubMed
    Score: 0.102
  53. Mechanisms of organ transplant injury mediated by B cells and antibodies: Implications for antibody-mediated rejection. Am J Transplant. 2020 06; 20 Suppl 4:23-32.
    View in: PubMed
    Score: 0.101
  54. Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group. Transplantation. 2020 05; 104(5):911-922.
    View in: PubMed
    Score: 0.100
  55. Skin-restricted commensal colonization accelerates skin graft rejection. JCI Insight. 2019 07 16; 5.
    View in: PubMed
    Score: 0.095
  56. Distinct Graft-Specific TCR Avidity Profiles during Acute Rejection and Tolerance. Cell Rep. 2018 08 21; 24(8):2112-2126.
    View in: PubMed
    Score: 0.089
  57. Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model. J Immunol. 1998 Aug 15; 161(4):2044-51.
    View in: PubMed
    Score: 0.089
  58. Modification of humoral responses by the combination of leflunomide and cyclosporine in Lewis rats transplanted with hamster hearts. Transplantation. 1997 Dec 27; 64(12):1650-7.
    View in: PubMed
    Score: 0.085
  59. From Pipe Dream to Donor-Specific PC Elimination: Novel Ways to Target Alloantibodies. Transplantation. 2016 11; 100(11):2238-2239.
    View in: PubMed
    Score: 0.079
  60. Delayed xenograft rejection in the concordant hamster heart into Lewis rat model. Transplantation. 1996 Jul 15; 62(1):90-6.
    View in: PubMed
    Score: 0.077
  61. The composition of the microbiota modulates allograft rejection. J Clin Invest. 2016 07 01; 126(7):2736-44.
    View in: PubMed
    Score: 0.077
  62. Adoptive Transfer of Tracer-Alloreactive CD4+ T Cell Receptor Transgenic T Cells Alters the Endogenous Immune Response to an Allograft. Am J Transplant. 2016 10; 16(10):2842-2853.
    View in: PubMed
    Score: 0.076
  63. Tracking of TCR-Transgenic T Cells Reveals That Multiple Mechanisms Maintain Cardiac Transplant Tolerance in Mice. Am J Transplant. 2016 10; 16(10):2854-2864.
    View in: PubMed
    Score: 0.076
  64. High-Fat Diet-Induced Obesity Enhances Allograft Rejection. Transplantation. 2016 05; 100(5):1015-21.
    View in: PubMed
    Score: 0.076
  65. Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine. Transplant Proc. 1996 Apr; 28(2):684.
    View in: PubMed
    Score: 0.076
  66. The influence of the microbiota on the immune response to transplantation. Curr Opin Organ Transplant. 2015 Feb; 20(1):1-7.
    View in: PubMed
    Score: 0.070
  67. Memory B cells in transplantation. Transplantation. 2015 Jan; 99(1):21-8.
    View in: PubMed
    Score: 0.069
  68. AST Cutting Edge of Transplantation 2013 Meeting Report: a comprehensive look at B cells and antibodies in transplantation. Am J Transplant. 2014 Mar; 14(3):524-30.
    View in: PubMed
    Score: 0.065
  69. Microbes and allogeneic transplantation. Transplantation. 2014 Jan 15; 97(1):5-11.
    View in: PubMed
    Score: 0.065
  70. B cells assist allograft rejection in the deficiency of protein kinase c-theta. Transpl Int. 2013 Sep; 26(9):919-27.
    View in: PubMed
    Score: 0.063
  71. Plasma cell densities and glomerular filtration rates predict renal allograft outcomes following acute rejection. Transpl Int. 2012 Oct; 25(10):1050-8.
    View in: PubMed
    Score: 0.058
  72. Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming. J Immunol. 2011 Jan 01; 186(1):214-21.
    View in: PubMed
    Score: 0.052
  73. Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft model. Am J Transplant. 2010 Jul; 10(7):1524-33.
    View in: PubMed
    Score: 0.051
  74. TLR signals promote IL-6/IL-17-dependent transplant rejection. J Immunol. 2009 May 15; 182(10):6217-25.
    View in: PubMed
    Score: 0.047
  75. CD4+ T cells are sufficient to elicit allograft rejection and major histocompatibility complex class I molecule is required to induce recurrent autoimmune diabetes after pancreas transplantation in mice. Transplantation. 2008 Apr 27; 85(8):1205-11.
    View in: PubMed
    Score: 0.044
  76. Multi-omics analysis of a pig-to-human decedent kidney xenotransplant. Nature. 2026 02; 650(8100):205-217.
    View in: PubMed
    Score: 0.037
  77. Immune cell quantification of in situ inflammation partitions human lupus nephritis into mechanistic subtypes. J Clin Invest. 2025 11 03; 135(21).
    View in: PubMed
    Score: 0.036
  78. Integrative multi-omics profiling in human decedents receiving pig heart xenografts. Nat Med. 2024 05; 30(5):1448-1460.
    View in: PubMed
    Score: 0.033
  79. Advancing mouse models for transplantation research. Am J Transplant. 2024 Aug; 24(8):1362-1368.
    View in: PubMed
    Score: 0.032
  80. Heterogeneity in allospecific T cell function in transplant-tolerant hosts determines susceptibility to rejection following infection. J Clin Invest. 2023 11 01; 133(21).
    View in: PubMed
    Score: 0.032
  81. Sex as a biological variable: Mechanistic insights and clinical relevance in solid organ transplantation. Am J Transplant. 2023 11; 23(11):1661-1672.
    View in: PubMed
    Score: 0.031
  82. Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report. Am J Transplant. 2023 01; 23(1):133-149.
    View in: PubMed
    Score: 0.030
  83. Transcriptionally Distinct B Cells Infiltrate Allografts After Kidney Transplantation. Transplantation. 2023 02 01; 107(2):e47-e57.
    View in: PubMed
    Score: 0.030
  84. Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance. J Immunol. 2002 May 15; 168(10):5352-8.
    View in: PubMed
    Score: 0.029
  85. Desensitizing highly sensitized heart transplant candidates with the combination of belatacept and proteasome inhibition. Am J Transplant. 2020 12; 20(12):3620-3630.
    View in: PubMed
    Score: 0.025
  86. Anti-galactose-alpha(1,3) galactose antibody production in alpha1,3-galactosyltransferase gene knockout mice after xeno and allo transplantation. Transpl Immunol. 2000 Jun; 8(2):129-37.
    View in: PubMed
    Score: 0.025
  87. Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report. Am J Transplant. 2020 10; 20(10):2652-2668.
    View in: PubMed
    Score: 0.025
  88. Reversing donor-specific antibody responses and antibody-mediated rejection with bortezomib and belatacept in mice and kidney transplant recipients. Am J Transplant. 2020 10; 20(10):2675-2685.
    View in: PubMed
    Score: 0.025
  89. Tolerance of T-independent xeno-antibody responses in the hamster-to-rat xenotransplantation model is species-restricted but not tissue-specific. Xenotransplantation. 2000 Feb; 7(1):48-57.
    View in: PubMed
    Score: 0.025
  90. Resilience of T cell-intrinsic dysfunction in transplantation tolerance. Proc Natl Acad Sci U S A. 2019 11 19; 116(47):23682-23690.
    View in: PubMed
    Score: 0.024
  91. In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression. Transplantation. 1999 Jul 15; 68(1):100-9.
    View in: PubMed
    Score: 0.024
  92. The pursuit of transplantation tolerance: new mechanistic insights. Cell Mol Immunol. 2019 04; 16(4):324-333.
    View in: PubMed
    Score: 0.023
  93. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation. Transplantation. 1998 Sep 27; 66(6):692-8.
    View in: PubMed
    Score: 0.022
  94. Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice. Transplantation. 1998 May 27; 65(10):1310-4.
    View in: PubMed
    Score: 0.022
  95. Differential effect of leflunomide on concordant xenogeneic islet graft rejection and recurrence of autoimmune diabetes. Transplant Proc. 1998 Mar; 30(2):463-4.
    View in: PubMed
    Score: 0.022
  96. Leflunomide-based immunosuppression for porcine islet xenotransplantation. Transplant Proc. 1998 Mar; 30(2):515.
    View in: PubMed
    Score: 0.022
  97. Effect of gene gun-mediated CTLA4IG and Fas ligand gene transfection on concordant xenogeneic islet graft rejection. Transplant Proc. 1998 Mar; 30(2):589.
    View in: PubMed
    Score: 0.022
  98. Quantitation of the changes in splenic architecture during the rejection of cardiac allografts or xenografts. Transplantation. 1997 Aug 15; 64(3):448-53.
    View in: PubMed
    Score: 0.021
  99. Granulocyte colony-stimulating factor immunomodulation in the rat cardiac transplantation model. Transplantation. 1996 Apr 15; 61(7):1122-5.
    View in: PubMed
    Score: 0.019
  100. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation. Transplant Proc. 1996 Apr; 28(2):691-2.
    View in: PubMed
    Score: 0.019
  101. Pharmacologically induced regression of chronic transplant rejection. Transplantation. 1995 Nov 27; 60(10):1065-72.
    View in: PubMed
    Score: 0.018
  102. Leflunomide controls rejection in hamster to rat cardiac xenografts. Transplantation. 1994 Oct 15; 58(7):828-34.
    View in: PubMed
    Score: 0.017
  103. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts. Transplant Proc. 1994 Jun; 26(3):1263-5.
    View in: PubMed
    Score: 0.017
  104. Leflunomide immunosuppression in rat small intestinal transplantation. Transplant Proc. 1994 Jun; 26(3):1599-600.
    View in: PubMed
    Score: 0.017
  105. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine. Transplantation. 1994 Apr 27; 57(8):1223-31.
    View in: PubMed
    Score: 0.017
  106. Daily determinations of serum lymphotoxin allows for accurate early diagnosis of hepatic allograft rejection. Transplant Proc. 1993 Feb; 25(1 Pt 2):928-30.
    View in: PubMed
    Score: 0.015
  107. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation. 2010 Sep 15; 90(5):540-6.
    View in: PubMed
    Score: 0.013
  108. The multiple facets of toll-like receptors in transplantation biology. Transplantation. 2008 Jul 15; 86(1):1-9.
    View in: PubMed
    Score: 0.011
  109. Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats. Transplantation. 2005 Jan 15; 79(1):17-22.
    View in: PubMed
    Score: 0.009
  110. FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation. Transplantation. 1998 Oct 15; 66(7):832-7.
    View in: PubMed
    Score: 0.006
  111. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats. Transplantation. 1998 Jul 15; 66(1):1-5.
    View in: PubMed
    Score: 0.006
  112. Effect of anti-CD4 monoclonal antibody combined with human CTLA4Ig on the survival of hamster liver and heart xenografts in Lewis rats. Transplantation. 1997 Jul 27; 64(2):317-21.
    View in: PubMed
    Score: 0.005
  113. Splanchnic transplantation. Transplant Proc. 1994 Jun; 26(3):1411-2.
    View in: PubMed
    Score: 0.004
  114. Allograft ultraviolet-B irradiation in rat small intestinal transplantation. Transplant Proc. 1994 Jun; 26(3):1624-5.
    View in: PubMed
    Score: 0.004
  115. Immunosuppressive effects of leflunomide in a cardiac allograft model. Transplant Proc. 1993 Feb; 25(1 Pt 1):745-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.